Applied Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-413
Closed -$241K 40
2023
Q4
$241K Hold
413
0.13% 35
2023
Q3
$222K Buy
+413
New +$213K 0.14% 34
2022
Q4
Sell
-863
Closed -$279K 43
2022
Q3
$279K Buy
863
+2
+0.2% +$634 0.19% 47
2022
Q2
$279K Buy
861
+11
+1% +$3.3K 0.19% 50
2022
Q1
$243K Hold
850
0.16% 50
2021
Q4
$235K Buy
+850
New +$215K 0.19% 45

Other funds holding LLY

Applied Capital's LLY Position: Q1 2024 in Review

Applied Capital sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 413 shares — an estimated $241K sold.

Applied Capital first reported a position in LLY in Q4 2021 and held it in 6 quarters. The position peaked at $279K in Q3 2022. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Applied Capital reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
  • Applied Capital sold 413 Eli Lilly shares in Q1 2024, an estimated $241K.
  • Applied Capital first reported a position in Eli Lilly in Q4 2021 and held it in 6 quarters.
  • Applied Capital's Eli Lilly position peaked at $279K in Q3 2022.
  • 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Applied Capital's 13F filing for Q1 2024, filed 23 Apr 2024.